GYBYS(SH:600332) Nan Fang Du Shi Bao·2025-06-03 12:15Group 1 - The core viewpoint of the news is that Guangzhou Wanglaoji Health Industry Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Group, has signed a cooperation agreement with Nepal's Chobari Trading Company to enter the South Asian market, marking a significant step in the company's international expansion [2][3] - The trade value between China and Nepal is projected to exceed 55 billion RMB from 2019 to 2024, with an annual growth rate of 11.7%, highlighting the strengthening economic ties between the two countries [3] - The cooperation is seen not only as a business opportunity but also as a bridge for cultural exchange between China and Nepal, with both parties emphasizing the importance of effective distribution networks to reach the South Asian market [3] Group 2 - During the visit, the delegation from Guangzhou Pharmaceutical Group met with Nepal's former Deputy Prime Minister and discussed the global expansion strategy of the Wanglaoji brand [4] - The delegation also visited Nepal's first listed pharmaceutical company, Om Mega Shree Pharmaceuticals, to explore collaboration opportunities in pharmaceuticals and traditional Chinese medicine [4] - Wanglaoji has already entered over 100 countries and regions globally, with accelerated international expansion efforts, including the launch of the English brand identity WALOVI in Kuala Lumpur [4]